Procter & Gamble Health Limited (BOM:500126)

Market Cap	103.77B +5.8%
Revenue (ttm)	14.08B +15.6%
Net Income	3.27B +30.1%
EPS	196.94 +30.3%
Shares Out	16.60M
PE Ratio	31.74
Forward PE	27.81
Dividend	155.00 (2.45%)
Ex-Dividend Date	Aug 21, 2026

Volume	313
Open	6,384.90
Previous Close	6,321.40
Day's Range	6,236.05 - 6,397.80
52-Week Range	4,699.70 - 6,701.40
Beta	0.23
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 6, 2026

About Procter & Gamble Health

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemical products in India and internationally. The company offers over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. Procter & Gamble Health Limited was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble H...

• Industry: Pharmaceutical Preparations
• Founded: 1967
• Employees: 1,326
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500126

Financial Performance

In fiscal year 2026, Procter & Gamble Health's revenue was 14.08 billion, an increase of 15.59% compared to the previous year's 12.18 billion. Earnings were 3.27 billion, an increase of 30.14%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 7, 2026

Data Sources Report a data error